Search Results for: Research
Our K2 Brochure breaks down the key differences between K1 and K2, explaining their mechanisms of action and the prevalence of deficiency in the population. Including compelling graphic design and messaging, it equips you with the tools to tell the important K2 story in a way that resonates with your audience.
As MenaQ7® K2 has solidified its clinical foundation in supporting strong bone and heart health, consumer awareness is on the rise. While this is excellent news, it also attracts less experienced K2 suppliers to the market. How do you ensure you’re selecting the best K2?
We are thrilled to bring you our Vitamin K2 Brochure, which provides all the insights you need to make a sound ingredient selection. It also equips you with essential elements to craft a compelling story about the importance and benefits of clinically proven MenaQ7®.
The Basics of Vitamin K and Beyond
When considering vitamin K for your product, it’s crucial to understand the distinction between its various forms, primarily K1 and K2. Your product’s effectiveness depends on featuring the most optimal form.
Our K2 Brochure breaks down the key differences between K1 and K2, explaining their mechanisms of action and the prevalence of deficiency in the population. Including compelling graphic design and messaging, it equips you with the tools to tell the important K2 story in a way that resonates with your audience.
What is the Target Audience for K2?
Proven effective in supporting bone and cardiovascular health — foundational across all life stages — Vitamin K2 can be strategically positioned to diverse demographics.
Whether targeting menopausal women, children’s early development, individuals leading active lifestyles, or those focused on longevity, our research and marketing tools offer invaluable support for your communication efforts.
Natural and Pure K2: For the Health of People and Planet
Crafted in the heart of Europe within our cGMP facility, our multi-step fermentation process mirrors nature’s own K2 production. Gain insight into our environmental management systems and the specific measures and commitments Gnosis has implemented to minimize our environmental footprint.
These factors distinguish MenaQ7® from newer market entrants, offering consumers a cherished value: natural, pure, and proven K2.
Clinically Proven MenaQ7® in a Wide Range of Applications
While MenaQ7® is the most clinically proven K2 as MK7 in the market, our efforts to substantiate new areas of importance are underway. Our developments allow you to stay one step ahead of the curve when it comes to clinical research, but also when it comes to innovative delivery systems. Our solutions platform caters to a wide range of finished products.
MenaQ7® is the K2 for brands that aspire for more – and this Brochure tells you why.
>Download Now!
In a world where only 7 % of adults in the US have optimal cardiometabolic health, our latest turnkey product tackles the issues head-on, combining MenaQ7® K2 and Ankascin 568-R. Our cardiometabolic health reflects the overall well-being of our metabolic and cardiovascular systems. It involves processes such as blood pressure regulation, lipid management, glucose metabolism, … Continue reading Introducing NEW MenaQ7® Metabolic
In a world where only 7 % of adults in the US have optimal cardiometabolic health, our latest turnkey product tackles the issues head-on, combining MenaQ7® K2 and Ankascin 568-R.
Our cardiometabolic health reflects the overall well-being of our metabolic and cardiovascular systems. It involves processes such as blood pressure regulation, lipid management, glucose metabolism, and waist circumference. By addressing both cardiovascular and metabolic aspects, our latest ready-to-launch supplement offers a complementary formulation in this space.
MenaQ7® & Ankascin®: A Complementary Approach
Our innovative formulation harnesses the power of two renowned ingredients: MenaQ7® K2 and Ankascin® 568 – R, an innovative red yeast rice extract. These carefully selected ingredients are backed by scientific research and proven efficacy. Combined they can provide complementary support for cardiometabolic health.
MenaQ7® is the most clinically proven K2 as MK7 for heart health.
Activates Matrix Gla Protein, the most potent inhibitor of calcification of arteries and soft tissues.
Daily supplementation is shown to inhibit age-related arterial stiffening and improve vascular elasticity.
Demonstrated efficacy in reducing visceral fat accumulation.
Ankascin® 568 – R is supported by more than 120 publications and the benefits are clinically validated to support healthy blood pressure, healthy lipid profile and healthy blood glucose level.
MenaQ7® Matrix: The Natural Way to K2 Protection
Central to this innovative formulation is MenaQ7® Matrix that offers the latest in vitamin K2 protection. Compared to microencapsulated alternatives in the market, the Matrix technology enables natural protection with the shortest list of ingredients with no additives and no coating. These attributes set the Matrix technology apart from microencapsulated K2 in the market.
Fast to Market with A Ready to Launch Product
At Gnosis, we understand the challenges of product development. With MenaQ7® Metabolic we have done the groundwork for you. This ready-to-market product eliminates your need for extensive research and development, saving you time and resources. With our expertise and unwavering commitment to quality, you can trust that our innovative formulation not only meets the highest standards but also addresses a critical need within the population.
This product is available for the US market only.
>Download the brochure today!
Vitamin K was initially known for its essential role in blood coagulation, a healthy process to prevent excessive bleeding when needed. This raises the question: Does vitamin K increase blood thickness, and does it elevate the risk of thrombosis? Vitamin K is essential for maintaining normal blood clotting abilities, ensuring our bodies can effectively … Continue reading Vitamin K2 and Blood Coagulation: Debunking A Myth
Vitamin K was initially known for its essential role in blood coagulation, a healthy process to prevent excessive bleeding when needed. This raises the question: Does vitamin K increase blood thickness, and does it elevate the risk of thrombosis?
Vitamin K is essential for maintaining normal blood clotting abilities, ensuring our bodies can effectively stop bleeding when necessary. Contrary to some belief, research shows that Vitamin K2 doesn’t cause excessive blood clotting. Today, we are debunking the myth that vitamin K2 can lead to elevated levels of coagulation.
Understanding Vitamin K
Historically, K vitamins were thought to be a single vitamin, referred to as Vitamin K. However, K vitamins are a group of fat-soluble vitamins whose function is significant for human health.
The two most important forms are Vitamins K1 (found in leafy greens) and vitamin K2 (small levels found in fermented foods). Vitamin K1 is the principal source of dietary Vitamin K and is needed for proper blood coagulation. Meanwhile, Vitamin K2 is essential to build and maintain strong bones and to support a robust cardiovascular system. The difference between the two is the fact that vitamin K2 stays in the blood longer, is more bioactive, and has additional functions not seen in K1.
The Relationship Between Vitamin K2 and Blood Coagulation
Prothrombin, a vitamin K-dependent protein, plays a crucial role in the blood clotting process. It does not influence blood “thickness or thinness. Instead, it is involved in the complex cascade of blood coagulation, where vitamin K activates not only prothrombin but also other clotting factors necessary for proper blood coagulation when needed. In healthy individuals, these clotting factors function optimally without increasing thrombosis risk. Vitamin K deficiency, on the other hand, leads to reduced activity in these clotting proteins, resulting in longer, sometimes harmful, bleeding time.
Vitamin K2 has the same ability to activate the proteins in the liver responsible for blood clotting as vitamin K1. However, as coagulation is an important process in the human body, vitamin K1 is primarily taken up and utilized by the liver, with little left for other tissues.
Coumarin is The Only Contraindication
The only contraindication is the use of coumarin derivatives, like warfarin, as oral anticoagulants. These drugs are prescribed to patients with an increased risk of developing harmful blood clots, due to disease, or after surgery. These drugs are vitamin K antagonists, inhibiting important actions of vitamin K2 in the body. This means that patients on these types of anticoagulants are at risk of poorer bone and cardiovascular health. Patients receiving coumarin treatment should always consult their doctor before supplementing with vitamin K2. Fortunately, there is a new generation of oral anticoagulants that are not vitamin K- antagonists and can be combined with vitamin K2 without hesitation.
Antithrombotic drugs and vitamin K2 Supplementation
Historically, vitamin K antagonists were the only anticoagulants widely available for human use. Due to the risks associated with bleeding and the need for careful monitoring, there’s been a push to develop safer anticoagulant medications that don’t require as much oversight. This has led to the creation of new types of antithrombotic drugs, that work by targeting specific parts of the blood clotting process to prevent clots from forming.
These drugs can be divided between anticoagulants and anti-platelet drugs. Examples of drugs that have no interference with vitamin K2 are anticoagulants like Heparins and so-called Direct Oral Anticoagulants. Anti-platelet drugs like aspirin also have no interference with K2.
MenaQ7® is Proven Safe and Efficacious
Across the many clinical studies performed with MenaQ7®, there has been no observed risk of coagulation elevation. There has been no show of negative impact on thrombin and coagulation parameters remain stable over time. Researched groups include children, adults, and kidney patients. This is yet another argument to promote the foundational health benefits of MenaQ7® Vitamin K2, across all age groups, supporting healthy development and healthy aging.
Fortunately, with the development of new oral anticoagulant (OAC) drugs mentioned earlier, individuals in these patient groups can safely continue supplementing with MenaQ7® to promote healthier bone and cardiovascular systems.
This post highlights opportunities for brand owners based on key consumer trends for 2024. It is all about finding the optimal ingredient setting your product apart from the competition. We believe MenaQ7® is such an optimal ingredient. Consumers prioritize ingredients for better value According to Innova Market Insights “Ingredients Taking the Spotlight”, is at the … Continue reading Key Consumer Trends to Pay Attention to in 2024
This post highlights opportunities for brand owners based on key consumer trends for 2024. It is all about finding the optimal ingredient setting your product apart from the competition. We believe MenaQ7® is such an optimal ingredient.
Consumers prioritize ingredients for better value
According to Innova Market Insights “Ingredients Taking the Spotlight”, is at the top of their identified consumer trend of 2024. In other words, the hero of the product is the ingredients within it. Consumers look for value in the ingredients within the product and one-third of consumers report looking at the ingredients of interest on the product packaging.
Despite the cost-of-living crisis, FMCG Gurus also highlights value as a key trend with consumers. Specifically, consumers seek value in the form of efficacy, quality, and convenience. They ask questions like; does the product serve my needs, is efficacy-proven, is it trustworthy and is the dose form appealing? A key takeaway from FMCG Gurus is that value is more important to consumers than the lowest price, and brands should focus on innovation rather than being a cheaper “me-too” product.
Consumers Prioritize Prevention and Look for Clinically Proven Ingredients
According to Innova Market 1 in 3 global consumers report being more proactive when it comes to their health and prioritize a strategy of prevention when it comes to their physical health. When asked what their major concerns related to physical health are, the response was 1: Weight Management 2: Heart Health 3: Bone and Joint Health.
As consumers are getting more educated, higher inspection of your product is taking place. Consumers expect evidence and proof of the efficacy relating to the claims attached to a product. Brand owners who can provide evidence and documentation as part of their product information will be in a stronger position to build trust with consumers. Choosing branded ingredients with clinical documentation is crucial in meeting this demand.
Natural Ingredients and Sustainability
Beyond proven and science-backed claims, consumers are still looking for natural ingredients that are free from artificial additives, preservatives, and chemicals. Consumers are increasingly conscious of the impact of their choices on personal health and the environment. Features like Organic and non-GMO are often associated with a holistic approach to health and well-being, resonating with consumers seeking a more natural and integrated approach to their health. FMCG Gurus highlights a growing focus on ingredient transparency, where consumers are increasingly attentive to product labels and seeking healthy, clean, and recognizable ingredients.
How MenaQ7® Align with Consumer Demands
With MenaQ7® we are very confident your product will be equipped with the tools to meet the scrutiny of today’s health-conscious consumer.
With 22+ published clinical studies, and more underway, it is the most clinically proven Vitamin K2 as MK-7 in the market, and the only clinically proven for both bone and cardiovascular health. Our core focus is to translate complex clinical data from our research into compelling marketing tools, offering robust support to our customers.
MenaQ7® is derived by a fermentation process that mimics how nature produces vitamin K2 as MK-7. The MenaQ7® portfolio is complete with free from attributes, including all known allergens, it is vegan-friendly and of course non-GMO.
Through in-house production, Gnosis ensures 100% transparency allowing for complete traceability and control throughout the production process. And you are welcome to have a closer look.
With the most comprehensive K2 Solutions Platform, the clinically proven health benefits of MenaQ7® can effectively be incorporated into a range of new and increasingly sought-after products such as gummies, chewables, dispersible powders, and more.
Choose MenaQ7® in your next product development and enjoy the confidence of a carefully-made marketing story and messaging that will earn consumers trust in your brand.
Reach out today and let us start the conversation.
After the holidays, many women see the new year as a chance for positive change and a fresh start. One important but often overlooked vitamin is Vitamin K2 as MK7, crucial for women’s health and longevity. It’s lacking in many of us, so including it in your routine can make a big difference. Establishing Daily … Continue reading Why Women Should Forge New Years Health Routines with MenaQ7® K2
After the holidays, many women see the new year as a chance for positive change and a fresh start. One important but often overlooked vitamin is Vitamin K2 as MK7, crucial for women’s health and longevity. It’s lacking in many of us, so including it in your routine can make a big difference.
Establishing Daily Routines Based in Knowledge
In pursuing a lifestyle that supports healthy aging and longevity, embracing lasting changes trumps fad diets or temporary trends. True well-being is often rooted in understanding our diets, and educating ourselves is critical.
Knowing what nutrients we are lacking, the documented effects of supplemental ingredients, and recognizing how they influence our health is a strong motivator in and of itself. Armed with this knowledge, we are better equipped to make lasting changes and avoid the limitations of a short-lived regime that will lead us back to square one.
The Overlooked Key to Women’s Healthy Longevity
Bone strength and cardiovascular health are two pivotal areas to consider in the quest for overall vitality, especially for a woman’s well-being.
From their teenage years to their early 20s, women build most of the bone mass that strengthens their skeleton. They obtain peak bone mass around 30 years of age. This means that the more calcium she “banked” during her teenage years and young adulthood, her bones will strengthen as she heads into motherhood and through menopause.
Although cardiovascular disease has been considered a “man’s disease,” it still represents a serious threat to women’s health, particularly after childbearing years when fertility hormones ensure a lower risk. Lancet reports that 35% of female mortality is caused by compromised cardiovascular health.
MenaQ7®: The K2 Proven to Support Women’s Bone and Cardiovascular Health
Because women are sadly under-represented in clinical studies, we are proud that MenaQ7® is clinically proven to support women’s bone and cardiovascular health, two of the most critical areas allowing women to thrive and age healthily. Our latest clinical research reinforcing the importance of MenaQ7® K2 in women’s health were presented in August 2023 at the esteemed European Society of Cardiology Congress. The post-hoc analysis of our 1-year study highlights that improved K2 status improves arterial stiffness and blood pressure in post-menopausal women.
K2 is Missing from Our Diet – Supplementation is the Answer
With all this in mind, Vitamin K2 should be a staple to support women— young and old—through all stages of their lives. If only a modern healthy diet would provide sufficient nutritional levels of K2. Unfortunately, this is not the case. Vitamin K2 (menaquinone 7), unlike its counterpart K1 present in leafy greens, is notably absent from modern diets unless you consume specific fermented foods daily.
Yet there is affordable insurance for Women’s Health:
Luckily, incorporating a daily MenaQ7® supplement is a proven and affordable insurance for female health. A small, consistent investment in our health that pays dividends in the long run. With knowledge comes consistency, and with consistency comes a real health change.
In a recent gathering of Vitamin K2 experts, the Gnosis Vitamin K2 Scientific Advisory Committee (K2SAC) held its inaugural meeting, marking a significant commitment to Vitamin K2 research. Led by Professor Leon Schurgers, a distinguished expert in the field, the committee expanded its global presence by adding two esteemed members, Dr. Stefanos Roumeliotis and Dr. … Continue reading Gnosis Vitamin K2 Scientific Advisory Committee: A Global Expansion and Commitment to Excellence
In a recent gathering of Vitamin K2 experts, the Gnosis Vitamin K2 Scientific Advisory Committee (K2SAC) held its inaugural meeting, marking a significant commitment to Vitamin K2 research. Led by Professor Leon Schurgers, a distinguished expert in the field, the committee expanded its global presence by adding two esteemed members, Dr. Stefanos Roumeliotis and Dr. Sola Bahous, reaffirming its dedication to pioneering advancements in Vitamin K2.
Vitamin K2 Science for the Future: Beyond Heart and Bone
Convening in Lille, France, the meeting saw Professor Schurgers and existing members Hogne Vik and Katarzyna Maresz welcome the new members, each bringing valuable expertise to the committee’s mission. Dr. Roumeliotis, who specializes in chronic disease research, is leading the MenaQ7® K2 VIKIPEDIA study. At the same time, Dr. Bahous, an expert in arterial stiffness and hypertension, is deeply engaged in the novel migraine study with MenaQ7® Vitamin K2.
The day started with an insightful lecture by Professor Schurgers, exploring the profound impact of Vitamin K2 on “Healthy Ageing and the Vitamin K2 Effect.” This set the stage for a day of collaboration, with the expanded team sharing insights from various areas of Vitamin K2 research. The overarching theme, “Exploring the Future of Vitamin K2,” captured the spirit of the meeting, reflecting the committee’s strengthened position with leaders in K2 research. The anticipation is significant for the future of Vitamin K2 as they seek to discover and confirm new benefits and applications for this critical nutrient.
Ushering in New Research Through Scientific Partnership
At the very front of global Vitamin K2 research, Gnosis, combined with its K2SAC partnership, actively collaborates with research teams worldwide. This effort, providing insights from various clinical studies, shed light on new indications for Vitamin K2. Jean-Francois Jeanne, Gnosis Substantiation & Applications Team Manager, highlighted the significance of the inaugural K2SAC meeting, emphasizing the committee’s role in galvanizing a worldwide network of researchers. Their focus on identifying specific population needs for Vitamin K2 and leading clinical evidence demonstrates a commitment to advancing global health.
This dedication speaks to Gnosis’ ongoing efforts to elevate the understanding and applications of Vitamin K2, supporting a healthier future for people worldwide.